NVDX3 for wrist fractures

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Aug 2024: Trial registered, NCT06532253
  2. 22 Aug 2024: Trial started, NCT06532253

The trials

NCT06532253: Long-term Safety Trial with NVDX3

State
Under way
Phase
Phase 1 and Phase 2
People
15 planned
Started
22 Aug 2024
Primary completion
Mar 2036
Arms
NVDX3 implant
Results
None posted
  1. 1 Aug 2024: Trial registered
  2. 22 Aug 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.